NCT02428218View on ClinicalTrials.gov

Placebo-Controlled Study of the Efficacy and Safety of BG00012 in Pediatric Subjects With Relapsing-Remitting Multiple Sclerosis (RRMS)

PHASE3WithdrawnINTERVENTIONAL
0
Timeline

Start Date

May 31, 2016

Primary Completion Date

January 31, 2027

Study Completion Date

January 31, 2027

Conditions
Relapsing-Remitting Multiple SclerosisRelapsing Forms of Multiple Sclerosis
Interventions
DRUG

dimethyl fumarate

enteric-coated microtablets

DRUG

Placebo

enteric-coated microtablets

Sponsors

Lead Sponsor

Biogen
All Listed Sponsors
lead

Biogen

INDUSTRY